BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16541425)

  • 1. Normal and prostate cancer cells display distinct molecular profiles of alpha-tubulin posttranslational modifications.
    Soucek K; Kamaid A; Phung AD; Kubala L; Bulinski JC; Harper RW; Eiserich JP
    Prostate; 2006 Jun; 66(9):954-65. PubMed ID: 16541425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines.
    Webber MM; Bello D; Quader S
    Prostate; 1996 Dec; 29(6):386-94. PubMed ID: 8977636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the dual 5 alpha-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines.
    Maria McCrohan A; Morrissey C; O'Keane C; Mulligan N; Watson C; Smith J; Fitzpatrick JM; Watson RW
    Cancer; 2006 Jun; 106(12):2743-52. PubMed ID: 16703599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
    Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
    Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttranslational nitrotyrosination of alpha-tubulin induces cell cycle arrest and inhibits proliferation of vascular smooth muscle cells.
    Phung AD; Soucek K; Kubala L; Harper RW; Chloë Bulinski J; Eiserich JP
    Eur J Cell Biol; 2006 Dec; 85(12):1241-52. PubMed ID: 17118269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and cellular localization of follicle-stimulating hormone receptor in normal human prostate, benign prostatic hyperplasia and prostate cancer.
    Mariani S; Salvatori L; Basciani S; Arizzi M; Franco G; Petrangeli E; Spera G; Gnessi L
    J Urol; 2006 Jun; 175(6):2072-7; discussion 2077. PubMed ID: 16697805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
    Yuan TC; Veeramani S; Lin FF; Kondrikou D; Zelivianski S; Igawa T; Karan D; Batra SK; Lin MF
    Endocr Relat Cancer; 2006 Mar; 13(1):151-67. PubMed ID: 16601285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
    Pang B; Zhang H; Wang J; Chen WZ; Li SH; Shi QG; Liang RX; Xie BX; Wu RQ; Qian XL; Yu L; Li QM; Huang CF; Zhou JG
    Prostate; 2009 Aug; 69(11):1176-87. PubMed ID: 19415690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An androgen-independent androgen receptor function protects from inositol hexakisphosphate toxicity in the PC3/PC3(AR) prostate cancer cell lines.
    Diallo JS; Péant B; Lessard L; Delvoye N; Le Page C; Mes-Masson AM; Saad F
    Prostate; 2006 Sep; 66(12):1245-56. PubMed ID: 16705740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y; Wolff DW; Lin MF; Tu Y
    Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells.
    Hsieh CL; Cai C; Giwa A; Bivins A; Chen SY; Sabry D; Govardhan K; Shemshedini L
    J Mol Endocrinol; 2008 Jul; 41(1):13-23. PubMed ID: 18469090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of purine-rich element binding protein (PUR) alpha as a novel treatment target for hormone-refractory prostate cancer.
    Inoue T; Leman ES; Yeater DB; Getzenberg RH
    Prostate; 2008 Jul; 68(10):1048-56. PubMed ID: 18386260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of microtubules containing posttranslationally modified tubulin in cochlear epithelial cells during development.
    Tannenbaum J; Slepecky NB
    Cell Motil Cytoskeleton; 1997; 38(2):146-62. PubMed ID: 9331219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy.
    Wasylyk C; Zambrano A; Zhao C; Brants J; Abecassis J; Schalken JA; Rogatsch H; Schaefer G; Pycha A; Klocker H; Wasylyk B
    Int J Cancer; 2010 Dec; 127(11):2542-53. PubMed ID: 20162578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate.
    Whittington K; Connors B; King K; Assinder S; Hogarth K; Nicholson H
    Prostate; 2007 Jul; 67(10):1132-42. PubMed ID: 17492653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rap2 regulates androgen sensitivity in human prostate cancer cells.
    Bigler D; Gioeli D; Conaway MR; Weber MJ; Theodorescu D
    Prostate; 2007 Oct; 67(14):1590-9. PubMed ID: 17918750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection, Distribution and Amount of Posttranslational α-Tubulin Modifications in Immortalized Rat Schwann Cells.
    Gadau SD
    Arch Ital Biol; 2015 Dec; 153(4):255-65. PubMed ID: 27168411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
    Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T
    Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
    Jackson KM; Frazier MC; Harris WB
    Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.